Anteris Technologies Global Corp. (AVR)
AVR Stock Price Chart
Explore Anteris Technologies Global Corp. interactive price chart. Choose custom timeframes to analyze AVR price movements and trends.
AVR Company Profile
Discover essential business fundamentals and corporate details for Anteris Technologies Global Corp. (AVR) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
13 Dec 2024
Employees
136.00
Website
https://anteristech.comCEO
Wayne Geoffrey Paterson
Description
Anteris Technologies Global Corp. is a structural heart innovator dedicated to discovering, developing, and bringing to market medical devices that enhance the well-being of patients grappling with aortic stenosis. The company's premier offering is the DurAVR transcatheter heart valve system, a pioneering transcatheter aortic valve engineered to treat aortic stenosis by precisely emulating the performance of a healthy human aortic valve. Beyond this, Anteris develops ADAPT anti-calcification tissue, a unique preparation that transforms xenograft tissue into robust bioscaffolds. These bioscaffolds are designed to simulate human tissue for various surgical repairs, notably in aortic valve replacement. Additionally, the ComASUR delivery system, a physician-designed balloon-expandable apparatus, features a reinforced, steerable catheter. This allows for highly accurate navigation through cardiac anatomy in a controlled manner, thereby mitigating potential damage to the aorta. Founded in 1999, Anteris Technologies Global Corp. operates out of Toowong, Australia.
AVR Financial Timeline
Browse a chronological timeline of Anteris Technologies Global Corp. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 10 Aug 2026
EPS estimate is -$0.21, while revenue estimate is $1.50m.
Earnings released on 12 May 2026
EPS came in at -$0.28 falling short of the estimated -$0.27 by -3.39%, while revenue for the quarter reached $494.00k , missing expectations by -35.57%.
Earnings released on 26 Feb 2026
EPS came in at -$0.75 falling short of the estimated -$0.50 by -49.01%, while revenue for the quarter reached $303.00k , beating expectations by +51.50%.
Earnings released on 12 Nov 2025
EPS came in at -$0.62 falling short of the estimated -$0.56 by -10.71%, while revenue for the quarter reached $429.00k , beating expectations by +39.51%.
Earnings released on 11 Aug 2025
EPS came in at -$0.58 falling short of the estimated -$0.50 by -16.00%, while revenue for the quarter reached $618.00k , missing expectations by -49.72%.
Earnings released on 13 May 2025
EPS came in at -$0.61 falling short of the estimated -$0.45 by -35.56%, while revenue for the quarter reached $556.00k , missing expectations by -4.84%.
Earnings released on 29 Apr 2025
EPS came in at -$0.82 , while revenue for the quarter reached $536.11k .
AVR Stock Performance
Access detailed AVR performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
